Avantor, Inc. (NYSE:AVTR – Free Report) – Stock analysts at Zacks Research boosted their FY2025 earnings estimates for shares of Avantor in a research note issued on Tuesday, March 25th. Zacks Research analyst D. Dey now anticipates that the company will earn $1.04 per share for the year, up from their prior forecast of $1.03. The consensus estimate for Avantor’s current full-year earnings is $1.06 per share. Zacks Research also issued estimates for Avantor’s Q4 2025 earnings at $0.31 EPS and Q2 2026 earnings at $0.24 EPS.
Avantor (NYSE:AVTR – Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same period in the prior year, the business earned $0.22 EPS.
Check Out Our Latest Analysis on Avantor
Avantor Stock Performance
AVTR stock opened at $16.17 on Friday. Avantor has a twelve month low of $15.37 and a twelve month high of $28.00. The firm has a market cap of $11.01 billion, a price-to-earnings ratio of 15.55, a PEG ratio of 1.55 and a beta of 1.30. The business’s fifty day simple moving average is $18.52 and its two-hundred day simple moving average is $21.49. The company has a quick ratio of 0.70, a current ratio of 1.07 and a debt-to-equity ratio of 0.54.
Insider Buying and Selling at Avantor
In other news, CAO Steven W. Eck sold 4,907 shares of the stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $86,019.71. Following the completion of the sale, the chief accounting officer now owns 40,604 shares in the company, valued at approximately $711,788.12. This represents a 10.78 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP James Bramwell sold 3,758 shares of the firm’s stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $65,877.74. Following the completion of the sale, the executive vice president now directly owns 87,379 shares of the company’s stock, valued at $1,531,753.87. The trade was a 4.12 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.50% of the company’s stock.
Hedge Funds Weigh In On Avantor
Several hedge funds and other institutional investors have recently modified their holdings of AVTR. Louisiana State Employees Retirement System increased its stake in Avantor by 0.3% during the 4th quarter. Louisiana State Employees Retirement System now owns 188,900 shares of the company’s stock valued at $3,980,000 after purchasing an additional 500 shares in the last quarter. Hantz Financial Services Inc. increased its position in shares of Avantor by 2.1% in the 3rd quarter. Hantz Financial Services Inc. now owns 24,900 shares of the company’s stock valued at $644,000 after acquiring an additional 503 shares during the period. Blue Trust Inc. raised its stake in Avantor by 6.9% in the 4th quarter. Blue Trust Inc. now owns 8,069 shares of the company’s stock worth $170,000 after acquiring an additional 522 shares during the last quarter. Pacer Advisors Inc. lifted its position in Avantor by 0.5% during the 4th quarter. Pacer Advisors Inc. now owns 99,825 shares of the company’s stock worth $2,103,000 after acquiring an additional 542 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Avantor by 10.5% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 6,257 shares of the company’s stock worth $132,000 after acquiring an additional 592 shares during the period. 95.08% of the stock is owned by hedge funds and other institutional investors.
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Further Reading
- Five stocks we like better than Avantor
- How to Choose Top Rated Stocks
- Ibotta Stock: Why the Buyback Looks Like a Bullish Bet
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Joby Aviation Stock: Analyst Confidence and Smart Money Align
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 3 Momentum Stocks Near 52-Week Highs to Watch for More Growth
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.